Dr Fendrick opened the conversation with the commonly prescribed DMARDs (disease-modifying antirheumatic drugs). But the group focused particularly on methotrexate, one of the most commonly prescribed ...

Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology has released its updated treatment guidelines for rheumatoid arthritis, ...

Please provide your email address to receive an email when new articles are posted on . Maximizing the disease-modifying benefits of methotrexate is one of the core principles behind the 2021 American ...

The American College of Rheumatology (ACR) has issued new guidelines on the treatment of rheumatoid arthritis, addressing questions about initial treatment with methotrexate and minimizing reliance on ...

Medically reviewed by Anita C. Chandrasekaran, MD Key Takeaways Methotrexate may cause modest weight gain, especially if you are underweight when you start treatment.If you gain weight on methotrexate ...

Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...

Disease-modifying drug therapies are being sought intensively for osteoarthritis (OA), but none have proved out thus far. A previous trial in patients with OA of the hand had found that methotrexate ...

Methotrexate is a first-line rheumatoid arthritis drug that reduces pain and swelling. It may also slow disease progression and help prevent joint damage. Many people notice less pain, swelling, and ...

Adding a tumor necrosis factor inhibitor to the treatment regimen of patients with psoriatic arthritis who failed to reach minimal disease activity on methotrexate monotherapy after 4 or more weeks ...

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that tuberculosis (TB) screening and ongoing clinical care is needed for people on methotrexate ...